Pharmacogenetic Expression of CYP2C19 in a Pediatric Population

Genetic variability in CYP2C19 may be associated with both lack of efficacy and toxicity of drugs due to its different metabolic status based on the presence of particular alleles. This literature review summarizes current knowledge relative to the association or treatment adaptation based on CYP2C1...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierre-François, Marie Josette Déborah, Gagné, Vincent, Brukner, Ivan, Krajinovic, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504170/
https://www.ncbi.nlm.nih.gov/pubmed/36143168
http://dx.doi.org/10.3390/jpm12091383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504170/
https://www.ncbi.nlm.nih.gov/pubmed/36143168
http://dx.doi.org/10.3390/jpm12091383

Ejemplares similares